> Program > Scientific Program
| Date / Time | 300, | |
|---|---|---|
| Channel | ||
| Speakers | 08:30-08:52 | Is chromoendoscopy still useful? |
| 08:52-09:14 | NBI, BLI, LCI and AFI with magnification | |
| 09:14-09:36 | Endocytoscopy: Japanese experience | |
| 09:36-09:58 | Rapid Fiber-Optic Raman Endoscopy: Immediate Medical Diagnosis in Gastrointestinal Tracts | |
| Date / Time | 300, | |
|---|---|---|
| Channel | ||
| Speakers | 10:15-10:37 | Lesion-based convolutional neural network in diagnosis of early gastric cancer |
| 10:37-10:59 | Computer-aided diagnosis for gastric mesenchymal tumors on EUS | |
| 10:59-11:21 | Computer-aided diagnosis of gastric neoplasms | |
| 11:21-11:43 | AI assisted esophageal cancer management | |
| Date / Time | 300, | |
|---|---|---|
| Channel | ||
| Speakers | 12:25-12:47 | The strategy to enhance adequate bowel preparation for colonoscopy |
| 12:47-13:09 | Polypectomy strategy based on size and morphology | |
| 13:09-13:31 | Post-polypectomy surveillance: What is changed? | |
| 13:31-13:53 | Management of direct oral anticoagulants for patients undergoing polypectomy | |
| Date / Time | 300, | |
|---|---|---|
| Channel | ||
| Speakers | 14:10-14:32 | Advances in non-invasive strategies for CRC screening |
| 14:32-14:54 | IEE for detection and differentiation of colorectal neoplasia: NBI and BLI | |
| 14:54-15:16 | Automatic polyp detection in colonoscopy | |
| 15:16-15:38 | Deep learning for histological prediction of colon polyp | |
| Date / Time | 300, | |
|---|---|---|
| Channel | ||
| Speakers | 15:55-16:15 | Cholangioscopy |
| 16:15-16:35 | Pancreatoscopy | |
| 16:35-16:55 | Intraductal ultrasonography | |
| 16:55-17:15 | Confocal laser endomicroscopy | |
| 17:15-17:25 | Case based discussion | |
| Date / Time | 300, | |
|---|---|---|
| Channel | ||
| Speakers | 15:55-16:17 | How to make a fun and memorable lecture on the gastroenterology? |
| 16:17-16:39 | The introduction of Asan Medical Center EGD education program with the simulators for residents and fellows | |
| 16:39-17:01 | Research ethics for gastroenterologists | |
| 17:01-17:23 | Lessons given to gastroenterologists in clinical practice through medical appraisal | |
| Date / Time | 300, | |
|---|---|---|
| Channel | ||
| Speakers | 08:30-08:52 | What is the best among various precut access including primary precut for ERCP? |
| 08:52-09:14 | RFA for palliative treatment of unresectable extrahepatic cholangiocarcinoma: Current status, future perspective and challenges | |
| 09:14-09:36 | Head-to-head comparison of developed EUS-guided biopsy needles | |
| 09:36-09:58 | EUS-acquired pancreatic cyst fluid analysis, where we are and where we go | |
| Date / Time | 300, | |
|---|---|---|
| Channel | ||
| Speakers | 10:15-10:37 | What is your choice for removing large sessile serrated lesions: Piecemeal or en bloc? |
| 10:37-10:59 | Small bowel endoscopy for unexplained iron deficiency anemia, should we do? | |
| 10:59-11:21 | Modified EMR or ESD for rectal neuroendocrine tumors, which one is better? | |
| 11:21-11:43 | Is radical surgery mandatory for deep submucosal colorectal cancer? | |
| Date / Time | 300, | |
|---|---|---|
| Channel | ||
| Speakers | 12:25-12:47 | Multi-omics analysis of endoscopy-derived pancreas organoids reveal novel targets for the treatment of pancreas ductal adenocarcinoma |
| 12:47-13:09 | Discovery of tumor heterogeneity with endoscopic minimal specimens | |
| 13:09-13:31 | Diagnosis of bile duct cancer: Novel brushing cytology or forceps biopsy | |
| 13:31-13:53 | EUS-guided through-the-needle microforceps biopsy for pancreas cystic lesions | |
| Date / Time | 300, | |
|---|---|---|
| Channel | ||
| Speakers | 14:10-14:32 | Indications and techniques of PEG |
| 14:32-14:54 | Complications related to PEG | |
| 14:54-15:16 | Percutaneous Radiological Gastrostomy and Jejunostomy | |
| 15:16-15:38 | Laparoscopic gastrostomy or jejunostomy in challenging cases | |
| Date / Time | 300, | |
|---|---|---|
| Channel | ||
| Speakers | 12:25-12:47 | Preoperative inspection and localization of early gastric cancer |
| 12:47-13:09 | Management of postoperative complications: Focusing on collaboration with gastroenterologists | |
| 13:09-13:31 | Nutritional management before and after gastrectomy | |
| 13:31-13:53 | Eradication of Helicobacter pylori after subtotal gastrectomy: Is it necessary? | |
| Date / Time | 300, | |
|---|---|---|
| Channel | ||
| Speakers | 14:10-14:32 | Role of endoscopy in the diagnosis of subepithelial tumor at upper GI tract |
| 14:32-14:54 | Multiparametric Imaging Approaches for Gastric GIST | |
| 14:54-15:16 | What are indications for endoscopic resection of gastric GIST? | |
| 15:16-15:38 | Laparoscopic and endoscopic cooperative surgery for treatment of gastric GIST | |
| Date / Time | 300, | |
|---|---|---|
| Channel | ||
| Speakers | 15:55-16:17 | Pathology, classification, and grading of gastrointestinal NET |
| 16:17-16:39 | Management of gastric NET | |
| 16:39-17:01 | Management of duodenal NET | |
| 17:01-17:23 | Systemic treatment for advanced gastrointestinal NEN | |
| Date / Time | 300, | |
|---|---|---|
| Channel | ||
| Speakers | 08:30-08:52 | Predicting therapeutic efficacy using receptor-targeted activatable probes |
| 08:52-09:14 | Clinical application of proteomics/metabolomics | |
| 09:14-09:36 | Emerging prospects of exosome: Regulation of cancer immune microenvironment | |
| 09:36-09:58 | Current and future pharmacological and surgical treatment options for NAFLD | |
| Date / Time | 300, | |
|---|---|---|
| Channel | ||
| Speakers | 10:15-10:37 | Proteogenomics analysis of human pancreatic ductal adenocarcinoma |
| 10:37-10:59 | Enhancing the immune response to pancreatic cancer: Lessons from the tumor microenvironment | |
| 10:59-11:21 | New immuno-oncology agents for patients with pancreatobiliary cancer | |
| 11:21-11:43 | Real-world experience of immune checkpoint blockade therapy for pancreatobiliary cancer | |
| Date / Time | 300, | |
|---|---|---|
| Channel | ||
| Speakers | 12:25-12:45 | Early diagnosis and proper monitoring of IBD in pediatrics and adolescents |
| 12:45-13:05 | Growth failure in pediatric and adolescent IBD patients: Significance and management | |
| 13:05-13:25 | Proper vaccination strategy for IBD patients | |
| 13:25-13:45 | Key elements for successful transitional care in IBD | |
| 13:45-13:55 | Discussion | |
| Date / Time | 300, | |
|---|---|---|
| Channel | ||
| Speakers | 15:55-16:15 | Update on management of IBD during pregnancy |
| 16:15-16:35 | Diagnosis and management of recurrent C. difficile infection in IBD | |
| 16:35-16:55 | Management of acute severe ulcerative colitis | |
| 16:55-17:15 | Diagnosis and management of extraintestinal manifestations in IBD | |
| 17:15-17:25 | Discussion | |
| Date / Time | 300, | |
|---|---|---|
| Channel | ||
| Speakers | 14:10-14:32 | The normal development of infant gut microbiota: Maternal and fetal factors |
| 14:32-14:54 | Pediatric GERD from infants to adolescents: Should we test? / Should we treat? | |
| 14:54-15:16 | Gut microbiota and childhood obesity | |
| 15:16-15:38 | Guidelines for the management of helicobacter pylori: What are the differences between adults and children? | |
| Date / Time | 300, | |
|---|---|---|
| Channel | ||
| Speakers | 08:30-08:50 | Esophageal HRM and esophagography |
| 08:50-09:10 | 24hr pH and impedance | |
| 09:10-09:30 | Intestinal transit and breath test | |
| 09:30-09:50 | Anorectal HRM and defecography | |
| 09:50-10:00 | Discussion | |
| Date / Time | 300, | |
|---|---|---|
| Channel | ||
| Speakers | 10:15-10:35 | Gut microbiota & IBS |
| 10:35-10:55 | Infection & IBS | |
| 10:55-11:15 | Diet therapies for IBS | |
| 11:15-11:35 | Medical treatment for IBS | |
| 11:35-11:45 | Discussion | |
| Date / Time | 300, | |
|---|---|---|
| Channel | ||
| Speakers | 14:10-14:30 | Tip for the diagnosis and treatment of protein-losing enteropathy |
| 14:30-14:50 | Review of current knowledge on absorptive disorders | |
| 14:50-15:10 | Optimal approach for small bowel bleeding | |
| 15:10-15:30 | Newest perspective in NSAID-induced enteropathy | |
| 15:30-15:40 | Discussion | |
| Date / Time | 300, | |
|---|---|---|
| Channel | ||
| Speakers | 12:25-12:50 | Transparency and ethics in scholarly publishing |
| 12:50-13:15 | Clinical endoscopy editors' advices for writing good response | |
| 13:15-13:40 | Strategy to receive acceptance letter from SCI journal | |
| 13:40-13:55 | Discussion | |
| Date / Time | 300, | |
|---|---|---|
| Channel | ||
| Speakers | 08:30-08:52 | Definition, epidemiology, and co-morbidities: Focusing on the changes |
| 08:52-09:14 | Diagnostic algorithm for identifying high-risk patients in NAFLD | |
| 09:14-09:36 | Updates on non-invasive assessment of liver steatosis and fibrosis | |
| 09:36-09:58 | Current and future pharmacological and surgical treatment options | |
| Date / Time | 300, | |
|---|---|---|
| Channel | ||
| Speakers | 10:15-10:37 | Guidelines for gastric cancer screening |
| 10:37-10:59 | Results from the national cancer screening program for gastric cancers in Korea | |
| 10:59-11:21 | Guidelines for colorectal cancer screening | |
| 11:21-11:43 | Results from the national cancer screening program for colorectal cancers in Korea (including population-based colonoscopy screening) | |